We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
-18.09%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
10 Year Est. Return
AUM
$361M
AUM Growth
-$191M
Cap. Flow
-$113M
Cap. Flow %
-31.25%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$361M 99.8%
5,788,317
-1,447,079
-20% -$113M
XLRN
2
DELISTED
Acceleron Pharma
XLRN
$719K 0.2%
8,000

Similar funds

Foresite Capital Management I's Q1 2020 Portfolio in Review

As of Q1 2020, Foresite Capital Management I held 2 positions worth $361M, down 35% from $552M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $113M in Q1 2020, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $113M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I's biggest Q1 2020 reduction was 10x Genomics, cutting an estimated $113M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $361M portfolio in Q1 2020.
  • Foresite Capital Management I opened 0 new positions and closed 0 in Q1 2020.
  • Foresite Capital Management I's portfolio value fell 35% quarter-over-quarter to $361M.

Based on Foresite Capital Management I's 13F filing for Q1 2020, filed 14 May 2020.